fda glp-1 compounding enforcement news National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger FDA and Novo Nordisk Warned

Comparing supplement effects to drug effects Any marketing that implies supplement results comparable to semaglutide or tirzepatide results is misleading

Seek urgent medical attention if you develop sudden or severe neurological symptoms, such as significant weakness, loss of coordination, visual disturbances, or confusion, as these may indicate more serious neurological complications requiring immediate assessment

GLP1 receptor agonists have been proven effective antidiabetic medications with possible cardiovascular benefits

Areas with thin skin, like the inner arms, inner thighs, and abdomen, should receive concentrations similar to facial products